List of Nabi Biopharmaceuticals patents

List of Nabi Biopharmaceuticals patents

List of Entefy patents

List of Recovery Force patents

List of Cytogel Pharma patents

List of companies in Four Seasons Ventures's investment portfolio

List of companies in SenseAI Ventures's investment portfolio

Patents where

Current Assignee

Name

is

Nabi Biopharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7247502 Hapten-carrier conjugates for treating and preventing nicotine addiction	Patent 7247502 was granted and assigned to Nabi Biopharmaceuticals on July, 2007 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7247502	July 24, 2007
	‌ US Patent 7531633 None	Patent 7531633 was granted and assigned to Nabi Biopharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7531633	May 12, 2009
	‌ US Patent 7291343 None	Patent 7291343 was granted and assigned to Nabi Biopharmaceuticals on November, 2007 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7291343	November 6, 2007
	‌ US Patent 8232072 Smoking cessation kit and method	Patent 8232072 was granted and assigned to Nabi Biopharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	8232072	July 31, 2012
	‌ US Patent 7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction	Patent 7776620 was granted and assigned to Nabi Biopharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7776620	August 17, 2010
	‌ US Patent 8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction	Patent 8026109 was granted and assigned to Nabi Biopharmaceuticals on September, 2011 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	8026109	September 27, 2011
	‌ US Patent 7449189 Glycoconjugate vaccines for use in immune-compromised populations	Patent 7449189 was granted and assigned to Nabi Biopharmaceuticals on November, 2008 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7449189	November 11, 2008
	‌ US Patent 7446205 Method for making nicotine hapten	Patent 7446205 was granted and assigned to Nabi Biopharmaceuticals on November, 2008 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7446205	November 4, 2008
	‌ US Patent 6936258 Staphylococcus antigen and vaccine	Patent 6936258 was granted and assigned to Nabi Biopharmaceuticals on August, 2005 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	6936258	August 30, 2005
	‌ US Patent 7030101 Compositions of β-glucans and specific antibodies	Patent 7030101 was granted and assigned to Nabi Biopharmaceuticals on April, 2006 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	7030101	April 18, 2006
	‌ US Patent 6875445 Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption	Patent 6875445 was granted and assigned to Nabi Biopharmaceuticals on April, 2005 by the United States Patent and Trademark Office.		Nabi Biopharmaceuticals		United States Patent and Trademark Office	6875445	April 5, 2005

11 results

0 selected

11 results

0 selected